MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches across all sgRNA positions with near-zero ...

Expanded newborn genetic screening can diagnose hundreds of actionable conditions, allowing for earlier treatment.

Precision medicine is entering a new era, driven by breakthroughs in genetic technology and Artificial Intelligence (AI).

Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP) Annual Meeting, held November 11-15, 2025 in Boston, MA. Key presentations at the conference highlighted ...

Dr. Joanne Mason discusses how Yourgene Health is advancing technologies that support long-read sequencing, reproductive health and accessible molecular diagnostics.

Terns Pharmaceuticals, Inc. ( TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid Leukemia December 8, 2025 4:30 PM EST ...

Ziosoft, a pioneer in advanced visualization (AV) and leader in robust AI Applications, is featuring its newest REVORAS-based software addition, including coronary plaque analysis (pending FDA ...

There was also a shared emphasis on expanding and integrating clinical trials through broadening trial eligibility criteria ...

Kate Middleton and Prince William returned to public view together on Remembrance Sunday, November 9, 2025, marking their ...

Yesterday’s Budget was billed as a defining moment for economic growth. On first impressions, it appears to have been a constructive day for infrastructure. There were ample mentions of infrastructure ...

As Africa’s finance landscape transforms through innovation, digitalization, and sustainable growth, Patrick Botchwey stands ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.